![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Analysis of EVG/COBI/FTC/TDF Compared to EFV/FTC/TDF By Race in Treatment Naïve Patients
|
|
|
Reported by Jules Levin
IDSA Oct 17-21 San Diego 2012
D Hardy1, P Ruane2, K Workowski3, H Liu4, M Rhee4, and D Piontkowsky4
1Cedars Sinai Medical Center, Los Angeles, CA; 2Peter J. Ruane, MD, Inc., Los Angeles, CA; 3Emory University, Atlanta, GA; 4Gilead Sciences Inc., Foster City, CA
![IDSA1.gif](../images/102912/102912-2/IDSA1.gif)
![IDSA2.gif](../images/102912/102912-2/IDSA2.gif)
![IDSA3.gif](../images/102912/102912-2/IDSA3.gif)
![IDSA4.gif](../images/102912/102912-2/IDSA4.gif)
![IDSA5.gif](../images/102912/102912-2/IDSA5.gif)
![IDSA6.gif](../images/102912/102912-2/IDSA6.gif)
![IDSA7.gif](../images/102912/102912-2/IDSA7.gif)
![IDSA8.gif](../images/102912/102912-2/IDSA8.gif)
![IDSA9.gif](../images/102912/102912-2/IDSA9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|